Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus
- 1 August 2002
- journal article
- clinical trial
- Published by Springer Nature in Journal of Human Hypertension
- Vol. 16 (8) , 539-547
- https://doi.org/10.1038/sj.jhh.1001447
Abstract
Journal of Human Hypertension is exclusively concerned with all clinical aspects of human hypertension. The journal publishes fully refereed original research papers from around the world.Keywords
This publication has 47 references indexed in Scilit:
- The possible association of in vivo leukocyte-platelet heterophilic aggregate formation and the development of diabetic angiopathyPlatelets, 2001
- Platelet α2-adrenoceptor alterations in patients with essential hypertension are normalized after treatment with doxazosin but not propranololJournal Of Hypertension, 2000
- Preactivated Peripheral Blood Monocytes in Patients With Essential HypertensionHypertension, 1999
- Effect of efonidipine, a novel dihydropyridine derivative, on myocardial metabolic changes induced by coronary artery ligation in dogs: comparison with nifedipineFundamental & Clinical Pharmacology, 1997
- Flow cytometric analysis of platelet activation markers CD62P and CD63 in patients with coronary artery diseaseEuropean Journal of Clinical Investigation, 1996
- National High Blood Pressure Education Program Working Group report on hypertension in diabetes.Hypertension, 1994
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Thrombin Induces Platelet Adhesion to Endothelial CellsSeminars in Thrombosis and Hemostasis, 1992
- Flow‐cytometric detection of surface membrane alterations and concomitant changes in the cytoskeletal actin status of activated plateletsCytometry, 1990
- Effect of the calcium entry blocker, Flunarizine, on ruthenium red uptake by endothelial cells following acute electrical stimulation of rabbit carotid arteriesBasic Research in Cardiology, 1985